MDCG 2019-16
Residual risks (information supplied by the manufacturer) 23.1 g 20.1 g Warnings or precautions (information on the label) 23.2 m 20.2 m Residual risks, contra-indications and any undesirable side-effects, (information in the instructions for use) 23.4 g - Minimum IT requirements (information in the instructions for use) 23.4.ab 20.4.1.ah
Download MDCG 2019-16
Information
Domain:
Source:
Link to this page:
Documents from same domain
Russia - Country Page - European Commission
ec.europa.euLast update: November 2017 1 Russia - Country Page 1. Available national programmes or funds that could provide support to Russian Horizon 2020 participants
Evaluation of Innovation Activities - European …
ec.europa.euJune 2012 Evaluation of Innovation Activities Guidance on methods and practices Evaluation of Innovation Activities Guidance on methods and practices
EN Horizon 2020 Work Programme 2018-2020
ec.europa.euHorizon 2020 - Work Programme 2018-2020 Health, demographic change and wellbeing Part 8 - Page 3 of 124 SC1-BHC-19-2019: Implementation research for maternal and child health..... 41
H2020 Programme - ec.europa.eu
ec.europa.eu5 Your policy should also: reflect the current state of consortium agreements on data management be consistent with exploitation and Intellectual Property Rights (IPR)
International Accounting Standard 39 Financial …
ec.europa.euEC staff consolidated version as of 18 February 2011 FOR INFORMATION PURPOSES ONLY 1 International Accounting Standard 39 Financial …
International Financial Reporting Standard 1
ec.europa.euEC staff consolidated version as of 21/06/2012, ²² EN – EU IFRS 1 FOR INFORMATION PURPOSES ONLY International Financial Reporting Standard 1
International Financial Reporting Standard 3 …
ec.europa.euEC staff consolidated version as of 18 February 2011 FOR INFORMATION PURPOSES ONLY 1 International Financial Reporting Standard 3 Business Combinations
Literature review Teachers’ core ... - ec.europa.eu
ec.europa.eu© European Commission 1 EUROPEAN COMMISSION Directorate-General for Education and Culture Lifelong learning: policies and …
WP243 ANNEX - FREQUENTLY ASKED QUESTIONS …
ec.europa.euWP243 ANNEX - FREQUENTLY ASKED QUESTIONS The objective of this annex is to answer, in a simplified and easy-to-read format, some of the key questions that organisations may have regarding the new requirements under the GDPR to appoint a
Teachers’ continuing professional development
ec.europa.eu© European Commission 2 Literature review Quality in Teachers’ continuing professional developmenti 1. Teacher Professional Development: the …
Related documents
895–951 POSITION STATEMENT 1443-9506/04/$36.00 …
www.heartfoundation.org.aufor those without contra-indications. Strong IA Among patients treated with fibrinolytic therapy who are not in a PCI-capable hospital, early or immediate transfer to a PCI-capable hospital for angiography, and PCI if indicated, within 24 hours is recommended. Weak IIA …
STOPP START Tool to Support Medication Review
mm.wirral.nhs.ukother drug interactions or contra-indications not listed here. The final decision to stop the drug should be weighed against the daily symptomatic benefit or prevention of rapid worsening of symptoms. Where there is any doubt with the above information please check that it is in line with